Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26:2–16.

Article  PubMed  Google Scholar 

Larson T, Nussenblatt RB, Sen HN. Emerging drugs for uveitis. Expert Opin Emerg Drugs. 2011;16:309–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.

Article  CAS  PubMed  Google Scholar 

Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R, Brézin AP, Chee SP, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals of Care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125:757–73.

Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001;108:1134–9.

Article  CAS  PubMed  Google Scholar 

Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, et al. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Surv Ophthalmol. 2016;61:1–17.

Article  PubMed  Google Scholar 

Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology 2009;116:2188–2198.e1.

Article  PubMed  Google Scholar 

Shah SS, Lowder CY, Schmitt MA, Wilke WS, Kosmorsky GS, Meisler DM. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992;99:1419–23.

Article  CAS  PubMed  Google Scholar 

Taylor SRJ, Habot-Wilner Z, Pacheco P, Lightman SL. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Ophthalmology 2009;116:797–801.

Article  PubMed  Google Scholar 

Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149:423–32.

Article  CAS  PubMed  Google Scholar 

Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, et al. A controlled trial of azathioprine in Behçet’s Syndrome. N. Engl J Med. 1990;322:281–5.

Article  CAS  PubMed  Google Scholar 

Mathews JD, Crawford BA, Bignell JL, Mackay IR. Azathioprine in active chronic iridocyclitis. A double-blind controlled trial. Br J Ophthalmol. 1969;53:327–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148:500–509.e2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saadoun D, Wechsler B, Terrada C, Hajage D, Le Thi Huong D, Resche-Rigon M, et al. Azathioprine in severe uveitis of Behçet’s disease. Arthritis Care Res (Hoboken). 2010;62:1733–8.

Article  CAS  PubMed  Google Scholar 

Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology 2008;115:1826–32.

Article  PubMed  Google Scholar 

Waszczyk-łączak M, Łazicka-Gałecka M, Chomicz L, Mucha K, Pączek L, Szaflik JP. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in polish patients treated for non-infectious uveitis. Ann Agric Environ Med. 2020;27:644–9.

Article  PubMed  Google Scholar 

Wong VG, Hersh EM. Methotrexate in the therapy of cyclitis. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:279–93.

Google Scholar 

Kaplan-Messas A, Barkana Y, Avni I, Neumann R. Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis. Ocul Immunol Inflamm. 2003;11:131–9.

Article  CAS  PubMed  Google Scholar 

Harada Y, Hiyama T, Kiuchi Y. Methotrexate effectively controls ocular inflammation in Japanese patients with non-infectious uveitis. Front Med (Lausanne). 2021;8:1–8.

Google Scholar 

Bom S, Zamiri P, Lightman S. Use of methotrexate in the management of sight-threatening uveitis. Ocul Immunol Inflamm. 2001;9:35–40.

Article  CAS  PubMed  Google Scholar 

Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol. 2005;89:806–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999;106:111–8.

Article  CAS  PubMed  Google Scholar 

Teoh SC, Hogan AC, Dick AD, Lee RWJ. Mycophenolate mofetil for the treatment of uveitis. Am J Ophthalmol. 2008;146:752–60.e1-3.

Sobrin L, Christen W, Foster CS. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology 2008;115:1416–22.

Article  PubMed  Google Scholar 

Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology 2003;110:1061–5.

Article  PubMed  Google Scholar 

Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye 2011;25:427–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larkin G, Lightman S. Mycophenolate mofetil. Ophthalmology 1999;106:370–4.

Article  CAS  PubMed  Google Scholar 

Thorne JE, Jabs DA, Qazi FA, Quan DN, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005;112:1472–7.

Article  PubMed  Google Scholar 

Rodriguez-Poncelas A, Miravet-Jiménez S, Casellas A, Barrot De JF, Puente L, Franch-Nadal J, et al. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol. 2015;99:1628–33.

Article  PubMed  Google Scholar 

Klisovic DD. Mycophenolate mofetil use in the treatment of noninfectious uveitis. Dev Ophthalmol. 2012;51:57–62.

Article  CAS  PubMed  Google Scholar 

Deuter CME, Doycheva D, Stuebiger N, Zierhut M. Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm. 2009;17:415–9.

Article  CAS  PubMed  Google Scholar 

Chen TS, Tsang WM, Enkh-Amgalan I, Hwang Y-S. Mycophenolate sodium in the treatment of corticosteroid-refractory non-infectious inflammatory uveitis (MySTRI study). Eye 2020;34:2098–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doycheva D, Zierhut M, Blumenstock G, Sobolewska B, Voykov B, Hohmann J, et al. Mycophenolate sodium for the treatment of chronic non-infectious uveitis of childhood. Br J Ophthalmol. 2016;100:1071–5.

Article  PubMed  Google Scholar 

Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology 2014;121:1863–70.

Article  PubMed